Like other sectors of healthcare, the pharmaceutical industry will see lots of changes that will lead to many of today’s practices, standards, and operations unrecognizable by 2020. The long-term success will be determined by the industry's ability to adapt to new realities.


Read the entire article here

Multinational pharmaceutical companies GlaxoSmithKline and Baxter have received approval from the drug controller of India to carry out human trials in India for their H1N1 swine-flu vaccine, according to latest news reports. Since India reported its first swine flu case in May, more than 20,000 people have been affected by the virus and 627 deaths have been reported so far. A study with volunteers would be conducted to determine whether the medicines of the two companies were safe for Indians.

Read the rest of the news...